Skip to main content
SpringerLink
Log in

The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects

  • Short Communications
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

We have studied the influence of food and dose (50, 100, 200 mg) on the oral systemic availability of the broad spectrum antifungal itraconazole and the pharmacokinetics after repeated dosing of 100 mg in six healthy volunteers.

The relative systemic availability of itraconazole capsules compared with solution averaged 39.8% in the fasting state but 102% in the post-prandial state. Food did not significantly affect the tmax of the capsules. Itraconazole AUC at single doses of 50, 100, and 200 mg had a ratio of 0.3:1:2.7, and the steady-state AUC (0–24) after 15 days of 100 mg was five times the single-dose AUC.

These findings suggest non-linear itraconazole pharmacokinetics in the range of therapeutically used doses. Furthermore, capsules should be given shortly after a meal to ensure optimal oral systemic availability.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Van Cutsem J, Van Gerven F, Janssen PAJ (1987) Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models. Rev Infect Dis 9: S15-S32

    Google Scholar 

  2. Cauwenbergh G (1987) Itraconazole: The first orally active antifungal for single-day treatment of vaginal candidosis. Curr Ther Res 41: 210–214

    Google Scholar 

  3. Delescluse J, Cauwenbergh G, Degreef H (1986) Itraconazole, a new orally active antifungal, in the treatment of pityriasis verscolor. Br J Dermatol 114: 701–703

    Google Scholar 

  4. Woestenborghs R, Lorreyne W, Heykants J (1987) Determination of itraconazole in plasma and animal tissues by high-performance liquid chromatography. J Chromatogr Biomed Appl 413: 332–337

    Google Scholar 

  5. SAS User's Guide (1985) SAS Institute, Cary

Download references

Author information

Authors and Affiliations

  1. Department of Drug Metabolism and Pharmacokinetics, Janssen Research Foundation, Turnhoutseweg 30, B-2340, Beerse, Belgium

    A. Van Peer, R. Woestenborghs, J. Heykants & R. Gasparini

  2. Department of Clinical Research and Development, Janssen Research Foundation, Turnhoutseweg 30, B-2340, Beerse, Belgium

    G. Gauwenbergh

Authors
  1. A. Van Peer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Woestenborghs
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Heykants
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Gasparini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Gauwenbergh
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Van Peer, A., Woestenborghs, R., Heykants, J. et al. The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects. Eur J Clin Pharmacol 36, 423–426 (1989). https://doi.org/10.1007/BF00558308

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00558308

Key words

Search

Navigation